Annual EBIT
-$53.77 M
-$14.81 M-38.01%
December 31, 2023
Summary
- As of February 22, 2025, ABEO annual earnings before interest & taxes is -$53.77 million, with the most recent change of -$14.81 million (-38.01%) on December 31, 2023.
- During the last 3 years, ABEO annual EBIT has risen by +$26.35 million (+32.89%).
- ABEO annual EBIT is now -1237.27% below its all-time high of $4.73 million, reached on December 31, 2013.
Performance
ABEO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$29.17 M
-$37.65 M-444.03%
September 30, 2024
Summary
- As of February 22, 2025, ABEO quarterly earnings before interest & taxes is -$29.17 million, with the most recent change of -$37.65 million (-444.03%) on September 30, 2024.
- Over the past year, ABEO quarterly EBIT has dropped by -$12.69 million (-76.96%).
- ABEO quarterly EBIT is now -246.49% below its all-time high of $19.91 million, reached on December 31, 2012.
Performance
ABEO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$67.80 M
-$17.44 M-34.62%
September 30, 2024
Summary
- As of February 22, 2025, ABEO TTM earnings before interest & taxes is -$67.80 million, with the most recent change of -$17.44 million (-34.62%) on September 30, 2024.
- Over the past year, ABEO TTM EBIT has dropped by -$14.03 million (-26.09%).
- ABEO TTM EBIT is now -364.66% below its all-time high of $25.62 million, reached on September 30, 2013.
Performance
ABEO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABEO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.0% | -77.0% | -26.1% |
| 3 y3 years | +32.9% | -358.5% | -38.1% |
| 5 y5 years | +5.1% | -67.9% | +10.7% |
ABEO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.0% | +33.9% | -444.0% | +37.5% | -159.5% | +23.4% |
| 5 y | 5-year | -38.0% | +33.9% | -444.0% | +38.7% | -159.5% | +35.4% |
| alltime | all time | -1237.3% | +33.9% | -246.5% | +38.7% | -364.7% | +35.4% |
Abeona Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.17 M(-444.0%) | -$67.80 M(+34.6%) |
| Jun 2024 | - | $8.48 M(-127.7%) | -$50.36 M(-33.2%) |
| Mar 2024 | - | -$30.63 M(+85.8%) | -$75.39 M(+40.2%) |
| Dec 2023 | -$53.77 M(+38.0%) | -$16.48 M(+40.5%) | -$53.77 M(+21.6%) |
| Sep 2023 | - | -$11.73 M(-29.1%) | -$44.23 M(+14.1%) |
| Jun 2023 | - | -$16.55 M(+83.8%) | -$38.78 M(+48.4%) |
| Mar 2023 | - | -$9.01 M(+29.7%) | -$26.12 M(-32.9%) |
| Dec 2022 | -$38.96 M(-52.1%) | -$6.94 M(+10.6%) | -$38.96 M(-50.5%) |
| Sep 2022 | - | -$6.28 M(+61.1%) | -$78.65 M(-0.1%) |
| Jun 2022 | - | -$3.90 M(-82.2%) | -$78.73 M(-11.1%) |
| Mar 2022 | - | -$21.84 M(-53.2%) | -$88.54 M(+8.9%) |
| Dec 2021 | -$81.28 M(+1.4%) | -$46.63 M(+633.1%) | -$81.28 M(+65.6%) |
| Sep 2021 | - | -$6.36 M(-53.6%) | -$49.09 M(+0.9%) |
| Jun 2021 | - | -$13.71 M(-6.0%) | -$48.64 M(+3.2%) |
| Mar 2021 | - | -$14.58 M(+1.0%) | -$47.14 M(-41.2%) |
| Dec 2020 | -$80.12 M(+5.6%) | -$14.44 M(+144.3%) | -$80.12 M(-1.9%) |
| Sep 2020 | - | -$5.91 M(-51.6%) | -$81.71 M(-12.3%) |
| Jun 2020 | - | -$12.21 M(-74.3%) | -$93.17 M(-11.2%) |
| Mar 2020 | - | -$47.56 M(+196.7%) | -$104.89 M(+38.2%) |
| Dec 2019 | -$75.88 M(+33.9%) | -$16.03 M(-7.7%) | -$75.88 M(-1.9%) |
| Sep 2019 | - | -$17.37 M(-27.4%) | -$77.33 M(+1.3%) |
| Jun 2019 | - | -$23.92 M(+28.9%) | -$76.37 M(+18.1%) |
| Mar 2019 | - | -$18.55 M(+6.2%) | -$64.69 M(+14.2%) |
| Dec 2018 | -$56.66 M(+107.5%) | -$17.48 M(+6.5%) | -$56.66 M(+19.0%) |
| Sep 2018 | - | -$16.42 M(+34.1%) | -$47.63 M(+30.3%) |
| Jun 2018 | - | -$12.24 M(+16.3%) | -$36.56 M(+12.2%) |
| Mar 2018 | - | -$10.53 M(+24.6%) | -$32.59 M(+19.3%) |
| Dec 2017 | -$27.31 M(+24.9%) | -$8.45 M(+58.2%) | -$27.31 M(+5.6%) |
| Sep 2017 | - | -$5.34 M(-35.5%) | -$25.86 M(+11.7%) |
| Jun 2017 | - | -$8.28 M(+57.8%) | -$23.14 M(+7.3%) |
| Mar 2017 | - | -$5.25 M(-25.1%) | -$21.57 M(-1.4%) |
| Dec 2016 | -$21.87 M(+50.6%) | -$7.00 M(+166.9%) | -$21.87 M(+27.1%) |
| Sep 2016 | - | -$2.62 M(-60.9%) | -$17.20 M(-16.7%) |
| Jun 2016 | - | -$6.70 M(+20.9%) | -$20.65 M(+14.3%) |
| Mar 2016 | - | -$5.54 M(+137.0%) | -$18.06 M(+24.4%) |
| Dec 2015 | -$14.52 M(-44.6%) | -$2.34 M(-61.5%) | -$14.52 M(-39.4%) |
| Sep 2015 | - | -$6.07 M(+47.7%) | -$23.95 M(+24.7%) |
| Jun 2015 | - | -$4.11 M(+105.7%) | -$19.20 M(-30.1%) |
| Mar 2015 | - | -$2.00 M(-83.0%) | -$27.46 M(+4.8%) |
| Dec 2014 | -$26.20 M(-654.1%) | -$11.77 M(+790.1%) | -$26.20 M(+70.0%) |
| Sep 2014 | - | -$1.32 M(-89.3%) | -$15.41 M(+8.9%) |
| Jun 2014 | - | -$12.37 M(+1578.4%) | -$14.15 M(>+9900.0%) |
| Mar 2014 | - | -$737.00 K(-24.6%) | -$133.00 K(-102.8%) |
| Dec 2013 | $4.73 M(-147.6%) | -$978.00 K(+1503.3%) | $4.73 M(-81.5%) |
| Sep 2013 | - | -$61.00 K(-103.7%) | $25.62 M(+132.9%) |
| Jun 2013 | - | $1.64 M(-60.2%) | $11.00 M(-1121.1%) |
| Mar 2013 | - | $4.12 M(-79.3%) | -$1.08 M(-89.1%) |
| Dec 2012 | -$9.92 M(+294.6%) | $19.91 M(-235.6%) | -$9.92 M(-62.1%) |
| Sep 2012 | - | -$14.68 M(+40.7%) | -$26.16 M(+97.2%) |
| Jun 2012 | - | -$10.43 M(+120.9%) | -$13.27 M(+160.7%) |
| Mar 2012 | - | -$4.72 M(-228.7%) | -$5.09 M(+102.3%) |
| Dec 2011 | -$2.52 M | $3.67 M(-305.8%) | -$2.52 M(-65.2%) |
| Sep 2011 | - | -$1.78 M(-20.8%) | -$7.24 M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | -$2.25 M(+4.8%) | -$7.75 M(+4.2%) |
| Mar 2011 | - | -$2.15 M(+104.5%) | -$7.44 M(+7.3%) |
| Dec 2010 | -$6.93 M(-28.4%) | -$1.05 M(-54.2%) | -$6.93 M(-8.4%) |
| Sep 2010 | - | -$2.30 M(+18.4%) | -$7.56 M(-17.9%) |
| Jun 2010 | - | -$1.94 M(+18.1%) | -$9.21 M(-1.6%) |
| Mar 2010 | - | -$1.64 M(-2.5%) | -$9.36 M(-3.3%) |
| Dec 2009 | -$9.68 M(-68.5%) | -$1.69 M(-57.2%) | -$9.68 M(-0.5%) |
| Sep 2009 | - | -$3.94 M(+88.3%) | -$9.73 M(+0.7%) |
| Jun 2009 | - | -$2.09 M(+6.8%) | -$9.66 M(-0.6%) |
| Mar 2009 | - | -$1.96 M(+12.9%) | -$9.72 M(-47.0%) |
| Dec 2008 | -$30.73 M(+67.0%) | -$1.74 M(-55.2%) | -$18.32 M(-38.9%) |
| Sep 2008 | - | -$3.87 M(+79.6%) | -$30.00 M(+8.0%) |
| Jun 2008 | - | -$2.15 M(-79.6%) | -$27.78 M(+1.6%) |
| Mar 2008 | - | -$10.56 M(-21.3%) | -$27.34 M(+48.6%) |
| Dec 2007 | -$18.40 M(+255.6%) | -$13.41 M(+712.5%) | -$18.40 M(+205.0%) |
| Sep 2007 | - | -$1.65 M(-3.5%) | -$6.03 M(+7.0%) |
| Jun 2007 | - | -$1.71 M(+5.1%) | -$5.64 M(+6.3%) |
| Mar 2007 | - | -$1.63 M(+55.5%) | -$5.30 M(+2.5%) |
| Dec 2006 | -$5.17 M(-46.2%) | -$1.05 M(-16.7%) | -$5.17 M(-40.5%) |
| Sep 2006 | - | -$1.26 M(-8.6%) | -$8.70 M(+0.8%) |
| Jun 2006 | - | -$1.37 M(-8.3%) | -$8.63 M(-12.0%) |
| Mar 2006 | - | -$1.50 M(-67.2%) | -$9.81 M(+1.9%) |
| Dec 2005 | -$9.62 M(+60.3%) | -$4.57 M(+285.7%) | -$9.62 M(+109.9%) |
| Sep 2005 | - | -$1.19 M(-53.6%) | -$4.58 M(-18.5%) |
| Jun 2005 | - | -$2.55 M(+94.4%) | -$5.63 M(+7.2%) |
| Mar 2005 | - | -$1.31 M(-381.8%) | -$5.25 M(-12.5%) |
| Dec 2004 | -$6.00 M(+10.6%) | $466.00 K(-120.9%) | -$6.00 M(-1.0%) |
| Sep 2004 | - | -$2.23 M(+2.4%) | -$6.06 M(+4.9%) |
| Jun 2004 | - | -$2.18 M(+5.4%) | -$5.78 M(+9.1%) |
| Mar 2004 | - | -$2.06 M(-609.6%) | -$5.30 M(-2.4%) |
| Dec 2003 | -$5.43 M(-37.6%) | $405.00 K(-120.8%) | -$5.43 M(-32.0%) |
| Sep 2003 | - | -$1.94 M(+14.7%) | -$7.97 M(-8.4%) |
| Jun 2003 | - | -$1.69 M(-22.8%) | -$8.71 M(-4.6%) |
| Mar 2003 | - | -$2.19 M(+2.3%) | -$9.13 M(+5.0%) |
| Dec 2002 | -$8.70 M(+37.9%) | -$2.14 M(-19.9%) | -$8.70 M(+7.3%) |
| Sep 2002 | - | -$2.67 M(+26.3%) | -$8.11 M(+11.4%) |
| Jun 2002 | - | -$2.12 M(+20.1%) | -$7.28 M(+7.9%) |
| Mar 2002 | - | -$1.76 M(+13.7%) | -$6.74 M(+6.9%) |
| Dec 2001 | -$6.31 M(+4.1%) | -$1.55 M(-15.9%) | -$6.31 M(-3.8%) |
| Sep 2001 | - | -$1.84 M(+16.4%) | -$6.55 M(+5.7%) |
| Jun 2001 | - | -$1.58 M(+19.1%) | -$6.20 M(-1.3%) |
| Mar 2001 | - | -$1.33 M(-26.0%) | -$6.29 M(+3.8%) |
| Dec 2000 | -$6.06 M(+80.9%) | -$1.80 M(+20.4%) | -$6.06 M(+16.3%) |
| Sep 2000 | - | -$1.49 M(-10.4%) | -$5.21 M(+20.7%) |
| Jun 2000 | - | -$1.67 M(+51.5%) | -$4.32 M(+25.1%) |
| Mar 2000 | - | -$1.10 M(+15.8%) | -$3.45 M(+9.6%) |
| Dec 1999 | -$3.35 M(-4.3%) | -$950.00 K(+58.6%) | -$3.15 M(+43.2%) |
| Sep 1999 | - | -$599.00 K(-25.1%) | -$2.20 M(+37.5%) |
| Jun 1999 | - | -$800.00 K(+0.1%) | -$1.60 M(+100.1%) |
| Mar 1999 | - | -$799.00 K | -$799.00 K |
| Dec 1998 | -$3.50 M(-22.6%) | - | - |
| Dec 1997 | -$4.52 M(-61.0%) | - | - |
| Dec 1996 | -$11.61 M(-3505.6%) | - | - |
| Dec 1995 | $341.00 K | - | - |
FAQ
- What is Abeona Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Abeona Therapeutics?
- What is Abeona Therapeutics annual EBIT year-on-year change?
- What is Abeona Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly EBIT year-on-year change?
- What is Abeona Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Abeona Therapeutics?
- What is Abeona Therapeutics TTM EBIT year-on-year change?
What is Abeona Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ABEO is -$53.77 M
What is the all time high annual EBIT for Abeona Therapeutics?
Abeona Therapeutics all-time high annual earnings before interest & taxes is $4.73 M
What is Abeona Therapeutics annual EBIT year-on-year change?
Over the past year, ABEO annual earnings before interest & taxes has changed by -$14.81 M (-38.01%)
What is Abeona Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ABEO is -$29.17 M
What is the all time high quarterly EBIT for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly earnings before interest & taxes is $19.91 M
What is Abeona Therapeutics quarterly EBIT year-on-year change?
Over the past year, ABEO quarterly earnings before interest & taxes has changed by -$12.69 M (-76.96%)
What is Abeona Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ABEO is -$67.80 M
What is the all time high TTM EBIT for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM earnings before interest & taxes is $25.62 M
What is Abeona Therapeutics TTM EBIT year-on-year change?
Over the past year, ABEO TTM earnings before interest & taxes has changed by -$14.03 M (-26.09%)